chrisvoncsefalvay/vaers-outcomes huggingface dataset:
6 hours post vax, the pt complained of pain in the arm and a blister starting to form, right deltoid is warm to the touch and pain at the injection site.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from product quality group. The reporter is the patient.  A 32-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 as dose 4 (booster), single (Lot number: GJ3275) at the age of 31 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 27Dec2020 as dose 1, single (Lot number: EK9231), on 16Jan2021 as dose 2, single (Lot number: EL3247) and on 05Oct2021 as dose 3 (booster), single (Lot number: EW0217) for covid-19 immunisation. The patient's relevant medical history included: "Pregnant" (unspecified if ongoing), notes: Other medical history: Pregnant; "known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: BUPROPION, start date: 01Oct2021. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19: Paxlovid .; Sender's Comments: Based on the information provided, a causal relationship between the suspected drug and the reported events Vaccination failure , COVID-19  cannot be excluded
Case number PHHY2014US068091 is an initial spontaneous report received from a pharmacist on 27 May 2014. This report refers to patient whose identifiers were not reported. Past medical history and concomitant medication were not reported. The patient was vaccinated with an initial dose of FLUVIRIN (batch number: not reported) intramuscularly on an unknown date. It was reported that on an unknown date after vaccination, the patient experienced painful and limited movement of arm. Arm affected was the arm the patient received the injection in. The outcome, seriousness and causality of the events were not reported.
Information has been received from an office manager concerning an 18 year old male patient who on 12-JUL-2010 was vaccinated with a fourth dose of RECOMBIVAX HB (lot number unspecified). The office manager reported that after the three doses of RECOMBIVAX HB were given to the patient, all blood work (hepatitis B surface antibody) came back negative, not immune (lab was 8). The patient had been vaccinated with at least one dose of lot# 603895/0748V. The patient required a fourth dose of the vaccine, on 12-JUL-2010 (lot number unspecified). At the time of the report the patient had not had follow up laboratories yet. The patient did not develop hepatitis B. No other adverse experience was reported. At the time of the report the patient's outcome was unknown. It was unspecified if the patient sought medical attention. The office wanted to know if lot# 603895/0748V was associated with failed immunity. Follow up information has been received from the office manager who reported that on 23-OCT-1992 (at the age of 8 months) the patient was vaccinated with a dose of RECOMBIVAX HB (lot number lot# 603895/0748V) (adult dose vaccine, actual dose not reported), as an infant. The office manager could not confirm if the vaccine was stored correctly back in 1992. A lot check has been initiated. A preliminary lot check investigation was performed. To date our investigation has found that this lot conformed to quality release parameters and the manufacturing was typical of a lot of RECOMBIVAX HB. Additional information will be provided upon finalization of this manufacturing investigation. Follow-up information has been received from an office manager who indicated that the currently 18 year old patient non-smoker with no pre-existing allergies or medical conditions on 08-SEP-1992 was vaccinated with a first dose of RECOMBIVAX HB (Lot# 603897/0750V). On 23-OCT-1992 the patient was vaccinated with a second dose of RECOMBIVAX HB (Lot# 603895/0748V). Concomitant vaccination included a fourth dose of B-CAPSA 1 (Lot# M015J2) administered in his left arm on 20-MAY-1993. On 02-SEP-1993 the patient was vaccinated with a third dose of ENGERIX-B (Lot# 1198A2) in his right arm, a fourth dose of TRIPEDIA (Lot# 3L71093) in his left arm and on 20-MAY-1993, the patient was vaccinated with a third oral dose of ORIMUNE (Lot# 3509430682K) in the left arm. On 09-JUN-2010 a Hepatitis B surface antibody (quant.) test was performed, with a result of 8. The result was verified by repeat analysis. It was reported that the patient did not have immunity to hepatitis B virus. That same day a varicella-Zoster virus IgG antibody test was performed, with a result of 2.44. On 18-JUN-2010 the reporter spoke to the patient's mom, who indicated that the patient was well. On 12-JUL-2010 the patient was vaccinated with a fourth dose of ENGERIX-B. On an unknown date another Hepatitis B surface antibody (quant.) test was performed, results were pending. The reporter considered the events to be non-serious. This is one of several reports received from the same source. Additional information is not expected. The patient had laboratory work (hepatitis B surface antibody quantitative).
About 3 days later felt tingling on left arm like previous Flu vaccine. Vaccine was administered on right arm but problems in left; similar to problems with previous Flu vaccine. Contacted the doctor immediately but asked to make apt. It was about 1 week before patient seen by doctor; still had tingling and weakness on left arm. Provider sent patient for X-ray and told results were inconclusive; also got an MRI again the results were inconclusive. Problems continued had several doctor follow-up visits. In October patient went to orthopedic surgeon-who helped with previous back injury. Dr. (Neurologist) diagnosed the brachial plexus neuropathy on left side of back within a few weeks. EMG test performed. Per doctor, patient lost 95% of muscle mass in left side of back. Patient was sent to physical therapy. Went to physical therapy 3 times per week and followed up with facility's neurologist. Condition would improve but about 6 months would have a relapse in terms of weakness and muscle fatigue for after 3 years frequent shooting pain (pinching pain) started on the left side. Patient consulted with various specialists to see what the best course of care. In July 2017 patient went to Dr., neurosurgeon, and had foraminal widening procedure on neck (C4-C7) to alleviate pinching. Pinching alleviated after procedure. In October 2017, went for physical therapy when lower back started giving problems. Patient presented with sciatic pain on both sides, after MRI, patient sent for lower back pain (L4-L5) Laminectomy on October 31. The surgery helped at first, resumed physical therapy in mid-December up to March. In March 2018, did not feel well again so went to Dr. who is evaluating him for 3rd surgery. Patient sent to MRI on 4/13; patient has not scheduled follow-up appointment yet. Patient will follow-up with Dr. (Physiatrist) on May 2nd. Currently pain level is at 10/10. Patient takes Gabapentin 3 times a day--started taking it roughly less than a month ago; patient has increased dose over time but currently at 800mg. Patient was unaware of NVICP after first follow-up visit with doctor.
Alopecia on the back of my head.  My wife originally noticed a bald spot on the back of my head.  I had just gotten a hair cut and thought the barber mistakenly cut a spot to close.  After a few weeks the spot got noticably larger.  Taken several localized steroid shots and seems to be helping
Started with symptoms of headache on 6/27/2021, and developed chills, sore throat, sinus drainage, and cough on 6/28/2021.  Had received the full vaccination series on 1/21/2021 and 2/11/2021.
ID verification was not verified upon check in.  Upon asking patient's name and DOB prior to COVID 19 injection, patient stated 9/14/2002.  Upon updating, it was discovered that patient's actual DOB is 9/14/2003.
given just the adjuvant portion; given just the adjuvant portion; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number G9JA7, expiry date 15th April 2023) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The medical assistant reported that, the patient was given just the adjuvant portion of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up. This case was linked with cases US2021215490 and US2021215486, reported by same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021215490:same reporter US-GLAXOSMITHKLINE-US2021215486:same reporter
Extremely debilitating pain in left shoulder that has increased since it has started. Frozen shoulder.
This spontaneous report as received from a pharmacist refers to two patients of unknown age and gender. On 16-SEP-2013, the patients were vaccinated with a dose of PROQUAD (SDV, MDV or Additive) (lot# J006869, expiration date reported as 14-DEC-2014, dose and indication not reported), subcutaneous, which was an order received into the pharmacy and placed into the refrigerator at normal refrigeration temperatures of 36-46 degrees Fahrenheit(F). No known adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Headache, Rash burnish rash right anterior chest at clavicle. Swollen lymph nodes, insomina
The patient called the pharmacy 1.5 hours later to vaccination. She reported face red and hot and itchy arms. I recommeded her go to emergency room or call the doctor. She didn't go to emergency room instead she said that she had Benadryl and then she took 2 capsules. I called her today at 8:23am and she said that is ok, today she don't have any symptoms.
Muscle pain, lymph node swelling/pain, back pain, neck pain, neck muscles shortened (I was stuck looking at the ceiling), headache, nausea, loss of appetite, vomiting, diarrhea, runny nose, sinus congestion, fatigue, insomnia, severe chills and hot flashes.
After vaccine was administered patient had a near syncopal episode. Patient was seated and then vomited twice. Patient was advised to stay seated for an additional 30 minutes, after which they felt comfortable enough to leave with his mother and two brothers. Patient seemed to be doing okay after calling their home for a follow-up 2 hours after vaccine event.
I had sore throat, fatigue, lack of awareness and response. I tested positive for COVID-19 at home. My wife took me to the hospital and they gave me antibodies and also found out I had congestion in my lungs. It took me about an hour to release what was happening when I was in the hospital.
Information has been received from a physician concerning a 15 month old white male with Down's syndrome and Teralogy of Fallot with primary repair, who on 26-AUG-2005 was vaccinated with a first dose in left anterior thigh of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot6475620579R).  Concomitant vaccine included a dose of varicella virus vaccine live (MSD).  It was noted that the patient's mother reported that the patient had a transient fever of 100-101 with all previous immunization.  In August 2005, the patient experienced an elevated fever that was greater than 103F.  Subsequently, the patient recovered.  Unspecified medical attention was sought.  No product quality complaint was involved.  No other information was provided.  Follow-up information from a physician indicated that the patient had a complete blood cell count on the date of the injection, 26 AUG-2005.  It was reported that on 01-SEP-2005 or 02-SEP-2005 the child became febrile to 104F with nasal congestion, rhinorrhea, and a moderate rose red rash over his torso.  The patient had a complete blood cell count during an emergency room visit at the onset of fever, on 05-SEP-2005.  The event lasted 3-5 days and the patient recovered by 06-SEP-2005.  Additional information is not expected.
Patient experienced pain in her shoulder for over 3 weeks. Starting 12/07 the pain started to disturb her sleep at night. No rash, lumps at the injection site.
Information has been received from a certified nurse practitioner concerning a 31 year old female with no pertinent medical history reported. The patient had her last menstrual period on 20-JAN-2008. On 30-JAN-2008, the patient was vaccainted with MMR II (lot # 1312U). Concomitant therapy also administered on 30-JAN-2008 included TWINRIX, influenza virus vaccine (unspecified) (manufacturer unspecified). poliovirus vaccine inactivated (Vero) (manufacturer unspecified), diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid (manufacturer unspecified), and typhoid vaccine live oral (Ty21a) (manufacturer unspecified). Concomitant therapy administered on 06-FEB-2008 included Japanese encephalitis virus vaccine (manufacturer unspecified), and rabies vaccine (unspecified) (manufacturer unspecified). Subsequently, she became pregnant. Her estimated date of delivery was 26-OCT-2008. On 27-FEB-2008, the patient had a pregnancy test. On 28-FEB-2008, the patient miscarried. Unspecified medical attention was sought. Subsequently, the patient recovered. Upon internal review, the spontaneous miscarriage was determined to be an Other Important Medical Event. Additional information has been requested.
Patient reported to me the day after her vaccine that she had chills, shivering, and a temp ranging from 100-101 Farenheit. Her arm felt like a log. She went to the hospital and had a negative Typhoid test, negative Malaria screen, normal urinalysis, a Hemoglobin of 9g/dl, and a WBC of 17,000. Today she reported that she did not have a good night. Her fever was better but she still had a severe headache and chills.
Patient experienced severe pain in left arm causing difficulty with tasks such as putting on a jacket and difficulty sleeping at night. Patient trying to treat w/ MOTRIN.
A physician reported that a 10-month old female received 3 injections of Prevnar (dates not specified). The patient's medical history included macrocephaly, "mild" gross motor delay and low carnitine levels. Concomitant therapy included carnitine. The patient experienced pneumococcal bacteremia and was said to be " very sick with fevers to 105 without a source". A blood culture revealed " many and early" Streptococcus pneumoniae. A repeat blood culture prior to initiation of antibiotic therapy was negative. The patient also experienced otitis. she was treated with 10 days of amoxicillin therapy and the events resolved. The events were considered to be "medically important" Follow-up info received on 01/02/2002 clarified the pt's age to be 9 months and the lot number of the vaccine.
This spontaneous report was received from a medical assistant referring to unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB which had lot # L014426, expiry date: 09-MAR-2018, (strength, dose, and route not reported). No adverse effect reported. No product quality complaint (PQC) involved. No further information provided. Additional information has been requested.
Within 1 day of vaccination: sore arm where shot was given shooting headache pains that lasted for a few seconds; sores on gums and mouth pallet. One week after vaccination joints in elbows were tender.
currently believe that I have shingles, and have just had the first injection of singrex; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th February 2020, the patient received the 1st dose of Shingrix. In February 2020, less than a week after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had shingles. The reporter asked would that mitigate the shingles rashes and what other effects might arise from this situation.
Scratchy throat, bronchial pain, sneezing, coughing, stuffy post nasal.
Information has been received from a registered nurse concerning a 15 month old caucasian female patient with lactose intolerences who on 10 jun 2000 was vaccinated subcutaneously with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # G32456/0173K).  Concomitant vaccinations that same day included a fourth dose via intramuscular administration of diphtheria toxioid (+) pertussia vaccine (+) tetanus toxoid (Lot # U0276RA), a fourth dose via intramuscular administration of haemophilus B conjugate vaccine ( Lot # 622363A), and a third dose via subcutaneous injection of poliovirus vaccine (IPOL) (Lot #r091).  On 20 Jun 2000, the patient experienced a measles like rash.  The patient sought unspecified medical attention.  It was reported that an additonal patient (waes# 00070993) had a similar experience following exposure to measles virus vaccine live (+) mumps virus vaccine live (+) rubella viurs vaccine live (second generation).  Follow up information from the registered nurse indicated that on 20 Jun 2000 the patient developed a rash which started on her face and then spread to her her trunk.  The patient was seen by the physician and the rash was thought to be consistent with a measles rash.  Subsequently the patient has recovered.  No further information is expected.
sore arm, jaw, lymphadenopathy; dx site inf by family MD; treated w/ATB-Duricef-fever x 2 days-subsided;
Post vax, pt experienced itching at the injection site and rash. She was treated with hydrocortisone.
This spontaneous report was received from a healthcare worker referring to a 6 month old patient of unknown gender. The patients' concurrent conditions and medical histories were not provided. On 19-OCT-2015, the patient was vaccinated with a dose of improperly stored ROTATEQ orally (dose was unknown, lot # K023532, expiration date 21-JUN-2016). Concomitant medication was not reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
On 03/02/2023, I boarded a flight out of state. Upon landing, I noticed that my ears had not cleared, and my head was stuffed up. I got to my hotel and still felt unclear, so I tested myself for COVID-19 and it was positive. I called my physician service and was prescribed Paxlovid. I took that from 03/03/2023-03/07/2023. The hotel immediately put me in quarantine for five and a half days. I had mild cold like symptoms. Stuffed up head and cough. No body aches or fever. At the end of the fifth day, the hotel allowed me to leave my room. I continued isolating and if I did have to go out, I was masked. I tested negative on 03/13/2023, which was the day I flew home. The head congestion dissipated after 7 days. The cough lingered for 4-5 more. I continue to test negative and am now completely healthy.
It began with a cough which was persistent that became productive which caused congestion and sinus congestion I had body aches and chills went to the doctor with fever and pressure in my right  ear. I had this condition for two weeks and was diagnosed with pneumonia.
Body and muscle aches, chills (without fever) and earache. Body aches lasted about 16 hours, and at peak were severe. Chills lasted for first 4 hours.  Earache was intermittent but frequent, quite severe stabbing pain. It occurred every few minutes for 10-12 hours, and diminished in frequency, but still occurred occasionally (every 2-3 hours) for another 24 hours.
Headache, Myalgia & Fever Narrative: Body Aches, headache, fevers, chills, GI upset, fatigue.
This spontaneous report was received from a medical assistant refers to an unspecified patients of unknown age. On an unknown date from 28-JUL-2016 to 03-OCT-2016, the patients were vaccinated with improperly stored GARDASIL, K009482, 06-MAR-2017 for 66 hours, previous excursion 10 Centigrade for 10 hours, Time 0.89 Centigrade. No adverse effects were reported. This is one of the several cases reported from the same reporter. Additional information has been requested.
diagnosed with leukemia; began losing weight; flu; Initial information was received on 18-Nov-2020 regarding an unsolicited valid serious social media case from a consumer/non health professional.  This case involves male patient (unknown age) who experienced flu (influenza) within 3 days, then 2 weeks later he began losing weight (weight decreased) and leukaemia, while he received INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient had a flu (influenza) within 3 days, then 2 weeks later he began losing weight (weight decreased) and leukaemia following the administration of INFLUENZA VACCINE. The event leukaemia and weight decreased were assessed as medically significant.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the events.  There will be no information available on the batch number for this case.; Sender's Comments: This was a poorly documented social media case involves a male patient (unknown age) who had influenza, weight decreased and leukaemia after vaccination with INFLUENZA VACCINE (unknown manufacturer). Time to onset is too short to be compatible for leukemia or vaccine failure. Based upon the reported information, the role of the vaccine is unlikely.
This spontaneous report was received from a registered nurse, refers to a patient of unknown age and gender. Concurrent condition or medical history were not reported. On 16-JUL-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) lot # K011081; expiration date on 08-AUG-2016 (strength, dose #, dose, anatomical location and route of administration were not informed). There were not a product quality issue involved. No adverse effect were reported. Additional information has been requested.
Anxious; Hyped up; This is a spontaneous report received from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced a little anxious and hyped up on an unspecified date. The outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Child woke up unable to bare weight on her lower extremities which later progressed to upper body weakness with a diagnosis of transverse myelitis.  Residual paralysis remains present two months later.